The process takes 5-10 business days and has a 35-40% initial approval rate in Canada
GLP-1 stimulates insulin secretion when blood glucose levels are elevated, suppresses glucagon release, and slows gastric emptying
Discontinuation rates (tolerability issues) 12.2% discontinued the 9 mg dose and 18.2% discontinued the 12 mg dose due to adverse events, compared to 4% in the placebo group
Those decisions are about symptom relief, quality of life, and a careful risk and benefit assessment with your provider
This is not a one-and-done prescription mill it is continuous telehealth care with real board-certified providers
Because survodutide also affects the glucagon receptor , researchers are curious about whether it could help with other conditions, including metabolic disorders and liver diseases